Recurrent Melanoma Withdrawn Phase Trials for Melphalan (DB01042)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02507076Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or SarcomaTreatment